rs139264192
Positions:
Variant summary
Our verdict is Benign. Variant got -11 ACMG points: 0P and 11B. BP4_StrongBP6_ModerateBP7BS2
The NM_015080.4(NRXN2):āc.3213C>Gā(p.Leu1071Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00257 in 1,614,202 control chromosomes in the GnomAD database, including 12 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ).
Frequency
Genomes: š 0.0020 ( 0 hom., cov: 32)
Exomes š: 0.0026 ( 12 hom. )
Consequence
NRXN2
NM_015080.4 synonymous
NM_015080.4 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.711
Genes affected
NRXN2 (HGNC:8009): (neurexin 2) This gene encodes a member of the neurexin gene family. The products of these genes function as cell adhesion molecules and receptors in the vertebrate nervous system. These genes utilize two promoters. The majority of transcripts are produced from the upstream promoter and encode alpha-neurexin isoforms while a smaller number of transcripts are produced from the downstream promoter and encode beta-neuresin isoforms. The alpha-neurexins contain epidermal growth factor-like (EGF-like) sequences and laminin G domains, and have been shown to interact with neurexophilins. The beta-neurexins lack EGF-like sequences and contain fewer laminin G domains than alpha-neurexins. Alternative splicing and the use of alternative promoters may generate thousands of transcript variants (PMID: 12036300, PMID: 11944992).[provided by RefSeq, Jun 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -11 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.53).
BP6
Variant 11-64648804-G-C is Benign according to our data. Variant chr11-64648804-G-C is described in ClinVar as [Benign]. Clinvar id is 211705.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr11-64648804-G-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.711 with no splicing effect.
BS2
High AC in GnomAd4 at 301 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NRXN2 | NM_015080.4 | c.3213C>G | p.Leu1071Leu | synonymous_variant | 16/23 | ENST00000265459.11 | NP_055895.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NRXN2 | ENST00000265459.11 | c.3213C>G | p.Leu1071Leu | synonymous_variant | 16/23 | 5 | NM_015080.4 | ENSP00000265459.5 | ||
NRXN2 | ENST00000704782.1 | c.3222C>G | p.Leu1074Leu | synonymous_variant | 15/22 | ENSP00000516031.1 | ||||
NRXN2 | ENST00000704781.1 | c.3222C>G | p.Leu1074Leu | synonymous_variant | 15/22 | ENSP00000516029.1 |
Frequencies
GnomAD3 genomes AF: 0.00198 AC: 301AN: 152200Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
301
AN:
152200
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00231 AC: 582AN: 251458Hom.: 2 AF XY: 0.00233 AC XY: 317AN XY: 135912
GnomAD3 exomes
AF:
AC:
582
AN:
251458
Hom.:
AF XY:
AC XY:
317
AN XY:
135912
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00263 AC: 3846AN: 1461884Hom.: 12 Cov.: 32 AF XY: 0.00254 AC XY: 1849AN XY: 727244
GnomAD4 exome
AF:
AC:
3846
AN:
1461884
Hom.:
Cov.:
32
AF XY:
AC XY:
1849
AN XY:
727244
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00198 AC: 301AN: 152318Hom.: 0 Cov.: 32 AF XY: 0.00185 AC XY: 138AN XY: 74488
GnomAD4 genome
AF:
AC:
301
AN:
152318
Hom.:
Cov.:
32
AF XY:
AC XY:
138
AN XY:
74488
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
5
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Nov 13, 2015 | - - |
NRXN2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Nov 16, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at